English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 17 Help

Selected(0)Clear Items/Page:    Sort:
SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice Journal article
Ren, Zhitao, Xiao, Gemin, Chen, Yixin, Wang, Linli, Xiang, Xiaoxin, Yang, Yi, Wen, Siying, Xie, Zhiyong, Luo, Wenhui, Li, Guowei, Zheng, Wenhua, Qian, Xiaoxian, Hai, Rihan, Yang, Liansheng, Zhu, Yanhua, Cai, Mengyin, Ye, Yinong, Shi, Guojun, Chen, Yanming. SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice[J]. Chinese Journal of Natural Medicines, 2023, 21(11), 830-841.
Authors:  Ren, Zhitao;  Xiao, Gemin;  Chen, Yixin;  Wang, Linli;  Xiang, Xiaoxin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.0/3.7 | Submit date：2023/12/18
Non-alcoholic Fatty Liver Disease  Mitochondrial Biogenesis  Traditional Chinese Medicine  Lipid Metabolism  Obesity  Clinical Observation  
Ginsenoside Rk2, a dehydroprotopanaxadiol saponin, alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice Journal article
Jian Zou, Rujie Yang, Ruibing Feng, Jiayue Liu, Jian Bo Wan. Ginsenoside Rk2, a dehydroprotopanaxadiol saponin, alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice[J]. Journal of Pharmaceutical Analysis, 2023, 13(9), 999-1012.
Authors:  Jian Zou;  Rujie Yang;  Ruibing Feng;  Jiayue Liu;  Jian Bo Wan
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:6.1/6.8 | Submit date：2023/10/10
Alcoholic Liver Disease  Ginsenoside Rk2  Intestinal Barrier Dysfunction  Nlrp3 Inflammasome  Nlrp6 Inflammasome  
Molecular mechanisms of autophagy and implications in liver diseases Journal article
Wu,Yuankai, Tan,Hayden Weng Siong, Lin,Jin Yi, Shen,Han Ming, Wang,Haihe, Lu,Guang. Molecular mechanisms of autophagy and implications in liver diseases[J]. Liver Research, 2023, 7(1), 56-70.
Authors:  Wu,Yuankai;  Tan,Hayden Weng Siong;  Lin,Jin Yi;  Shen,Han Ming;  Wang,Haihe; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:2.0/0 | Submit date：2023/08/03
Acetaminophen (Apap)  Alcohol-related Liver Disease (Arld)  Autophagy  Hepatocellular Carcinoma (Hcc)  Non-alcoholic Fatty Liver Disease (Nafld)  Viral Hepatitis  
Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease Journal article
Shasha Cheng, Yi Kuang, Guodong Li, Jia Wu, Chung-Nga Ko, Wanhe Wang, Dik-Lung Ma, Min Ye, Chung-Hang Leung. Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease[J]. Pharmaceuticals, 2022, 16(1), 14.
Authors:  Shasha Cheng;  Yi Kuang;  Guodong Li;  Jia Wu;  Chung-Nga Ko; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:4.3/4.6 | Submit date：2023/02/08
Alcoholic Liver Disease (Ald)  Glycogen Synthase Kinase 3β (Gsk3β)  Hepatoprotective  Keap1–nrf2 Protein–protein Interaction (Ppi)  
Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment Journal article
Chun‑Yong Sun, Le‑Le Yang, Pan Zhao, Pei‑Zheng Yan, Jia Li, Dong‑Sheng Zhao. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment[J]. HEREDITAS, 2022, 159(1), 44.
Authors:  Chun‑Yong Sun;  Le‑Le Yang;  Pan Zhao;  Pei‑Zheng Yan;  Jia Li; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:2.1/2.6 | Submit date：2023/01/30
Cynarine  Non‑alcoholic Fatty Liver Disease  Network Pharmacology  Integration Analysis  Molecular Docking  
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats Journal article
Li, Qiao Ping, Dou, Yao Xing, Huang, Zi Wei, Chen, Han Bin, Li, Yu Cui, Chen, Jian Nan, Liu, Yu Hong, Huang, Xiao Qi, Zeng, Hui Fang, Yang, Xiao Bo, Su, Zi Ren, Xie, Jian Hui. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats[J]. Phytomedicine, 2021, 85, 153550.
Authors:  Li, Qiao Ping;  Dou, Yao Xing;  Huang, Zi Wei;  Chen, Han Bin;  Li, Yu Cui; et al.
Favorite | TC[WOS]:34 TC[Scopus]:36  IF:6.7/6.2 | Submit date：2021/12/07
Ampk Signaling Pathway  Berberine  Insulin Signaling Pathway  Non-alcoholic Fatty Liver Disease  Obesity  Oxyberberine  
Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat Journal article
Lan, Qingping, Ren, Zhitao, Chen, Yan, Cui, Guozhen, Choi, I. Cheong, Ung, Carolina Oi Lam, Yu, Hon Ho, Lee, Simon Ming Yuen. Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat[J]. Chinese Medicine, 2021, 16(1).
Authors:  Lan, Qingping;  Ren, Zhitao;  Chen, Yan;  Cui, Guozhen;  Choi, I. Cheong; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:5.3/5.5 | Submit date：2021/12/09
Non-alcoholic Fatty Liver Disease  Non-alcoholic Steatohepatitis  Traditional Chinese Medicine  Qushihuayu  Mapk Pathway  Ppar-γ  P-p65  Fibrosis  Inflammation  Hscs Reprogramming  Methionine-choline Defcient Diet  
β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway Journal article
Xu, Nan, Luo, Huijuan, Li, Minyao, Wu, Jiazhen, Wu, Xue, Chen, Liping, Gan, Yuxuan, Guan, Fengkun, Li, Mengyao, Su, Ziren, Chen, Jiannan, Liu, Yuhong. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway[J]. Biomedicine and Pharmacotherapy, 2021, 134.
Authors:  Xu, Nan;  Luo, Huijuan;  Li, Minyao;  Wu, Jiazhen;  Wu, Xue; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20  IF:6.9/6.8 | Submit date：2021/12/07
Amp-activated Protein Kinase  Hepatic Steatosis  Non-alcoholic Fatty Liver Disease  Pogostemon Cablin  Β-patchoulene  
Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19 Other
2021-02-01
Authors:  Ji, Dong;  Zhang, Mingjie;  Qin, Enqiang;  Zhang, Lunqing;  Xu, Jing; et al.
Favorite | TC[WOS]:18 TC[Scopus]:19 | Submit date：2021/12/07
Covid-19  Deep Vein Thrombosis  Non-alcoholic Fatty Liver Disease  
Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials Journal
创刊日期: 2021, 收录类别: SCIE, ISSN: 1749-8546
Authors:  Liang,Zuanji;  Chen,Xianwen;  Shi,Junnan;  Hu,Hao;  Xue,Yan; et al.
Favorite | TC[WOS]:16 TC[Scopus]:20 | Submit date：2021/03/01
Consort-chm  Non-alcoholic Fatty Liver Disease  Randomized Clinical Trial  Rct  Risk Of Bias  Traditional Chinese Medicine